SMTL ID : 5j1w.1 (2 other biounits)

Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound 14)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.42 Å

Oligo State

monomer

Ligands

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 7 residues within 4Å: Chain A: P.114, F.115, R.116, L.117, Y.228, L.296, H.302 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.117, A:Y.228 Water bridges: A:D.118 GOL.2: 3 residues within 4Å: Chain A: G.9, D.10, V.11 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.10, A:V.11, A:V.11 GOL.3: 5 residues within 4Å: Chain A: N.50, C.55, R.59, E.87, I.92 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.50, A:E.87 GOL.4: 8 residues within 4Å: Chain A: L.22, L.99, G.100, L.101, S.102, D.105, L.150 Ligands: 6FB.6 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.102, A:D.105, A:D.105 Water bridges: A:L.99 GOL.5: 3 residues within 4Å: Chain A: S.239, K.263, Y.266 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.198, A:S.239, A:K.263, A:Y.266, A:Y.266

1 x 6FB: pyrido[3,4-g]quinazolin-2-amine(Non-covalent)

6FB.6: 14 residues within 4Å: Chain A: L.22, V.30, A.44, K.46, E.61, F.96, E.97, L.98, L.99, G.100, L.150, V.179, D.180 Ligands: GOL.4 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.30, A:V.30, A:F.96, A:V.179 Hydrogen bonds: A:L.99, A:L.99, A:D.180

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Esvan, Y.J. et al., Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure. Eur.J.Med.Chem. (2016)

Release Date

2016-05-04

Peptides

Dual specificity protein kinase CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase CLK1

Related Entries With Identical Sequence